The Impact of Exuberance on Equipoise in Oncology Clinical Trials: Sotorasib as Archetype
Oncologist
.
2024 Apr 4;29(4):275-277.
doi: 10.1093/oncolo/oyae042.
Authors
Tito Fojo
1
2
,
Meredith LaRose
1
,
Susan E Bates
1
2
Affiliations
1
Department of Medicine and Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA.
2
James J. Peters Veterans Administration Medical Center, Bronx, NY, USA.
PMID:
38498045
PMCID:
PMC10994247
DOI:
10.1093/oncolo/oyae042
No abstract available
MeSH terms
Drug Approval*
Humans
Patient Selection
Piperazines*
Proto-Oncogene Proteins p21(ras)
Pyridines*
Pyrimidines
Vereinigte Staaten
Substances
Piperazines
Proto-Oncogene Proteins p21(ras)
Pyridines
Pyrimidines
sotorasib